Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03313115 · ClinicalTrials.gov registry record
Sleep/Wake Protocol Implementation to Improve Sleep Quality in the ICU
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 685
- Enrollment target
NCT03313115: Completed study, sponsored by University of Utah.
NCT03313115 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 685 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03313115 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 685 participants
- Enrollment target
Study Summary
The purpose of this study is to analyze a multi-component sleep/wake protocol for optimization of environmental factors (noise, light, nursing activities) as well as non-environmental factors (pain, mechanical support devices, procedures) to improve quality of sleep and decrease incidence of ICU delirium in the Cardiovascular and Surgical ICU (CVICU/SICU).
Primary Outcome
Participants will be evaluated for delirium using the Confusion Assessment Method for the ICU (CAM-ICU)
Interventions
- BEHAVIORAL Sleep/Wake Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 685 participants |
| Start Date | 2017-10-11 |
| Est. Completion | 2018-03-14 |
What the finished NCT03313115 record still lists
NCT03313115 is an observational study that tracks outcomes without assigning an intervention. The registered 685 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sleep/Wake Protocol is the first listed.
NCT03313115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03313115 about?
NCT03313115 is a clinical study titled "Sleep/Wake Protocol Implementation to Improve Sleep Quality in the ICU". The purpose of this study is to analyze a multi-component sleep/wake protocol for optimization of environmental factors (noise, light, nursing activities) as well as non-environmental factors (pain, mechanical support devices, procedures) to improve quality of sleep and decrease incidence of ICU del...
What is the current status of trial NCT03313115?
This trial is currently completed. The enrollment target is 685 participants. The study started on 2017-10-11. Estimated completion is 2018-03-14.
What interventions are being tested in trial NCT03313115?
The interventions under investigation include: Sleep/Wake Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT03313115?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- NCT06459180 · 686 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI